Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomarin Pharmaceutical

57.29
-1.0800-1.85%
Post-market: 57.11-0.1800-0.31%19:38 EDT
Volume:1.74M
Turnover:100.31M
Market Cap:10.99B
PE:21.18
High:58.79
Open:58.47
Low:57.02
Close:58.37
Loading ...
Jan 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 21, 2023

Major Issues Report

Form 8-K - Current report
Dec 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2023

Major Issues Report

Form 8-K - Current report
May 30, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities